AzTrials
AzTrials

Sedentary LifestyleNCT04112329

Exergaming for Better Physical Fitness

A study testing Exergaming in people with Sedentary Lifestyle, run by Norwegian University of Science and Technology at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to increased physical activity, aerobic fitness and health benefits in sedentary adults. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Sedentary Lifestyle
What is being tested?
Exergaming
Could I receive a placebo?
No, everyone receives an active treatment
How many people
29 participants
Where
1 siteNorway
Study dates
14 Oct 2019to 1 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Sedentary (<150 mins of moderate intensity physical activity/week) and/or do not regularly take part in endurance training.
  • Able to ride a bike for up to 60 minutes

Who cannot join

  • Known cardiovascular disease
  • Taking beta-blockers or anti-arrhythmic drugs

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • Department of Circulation and Medical Imaging

    Trondheim, 7491

Other trials in Norway

About this study

Official title: Effects of 8 Weeks of High-intensity Exergaming on Cardiorespiratory Fitness and Physical Activity Levels in Sedentary Adults

The purpose of this project is to assess if playing a newly developed videogame that require physical activity (e.g. exergame) can lead to increased physical activity, aerobic fitness and health benefits in sedentary adults. The project will include 28 sedentary adults, 18 years and above, who are not sufficiently active according to current guidelines defined as doing (<150 minutes/week of moderate intensity physical activity or <75 minutes/week of vigorous physical activity and/or do not do any regular endurance training ). The physical fitness (maximal oxygen consumption), blood pressure, body composition and objectively measured physical activity will be tested before and after the intervention period.

Also, the participants gaming frequency will be registered throughout the 8 week period. Aim of this study is to investigate if access to this game can provide health benefits for adults who are not motivated to take part in regular physical activity.

Being tested
Exergaming
Keywords
Exercise therapy, Physical fitness, Gaming, Child, Healthy lifestyle, Fitness testing
Medical subject headings
Sedentary Behavior

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ExergamingBehavioural

    will use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks.

Study groups in NCT04112329
Study groupRoleWhat they receive
ExergamingExperimentalWill use the PlayPulse exergame for 45 minutes a minimum of two times per week for 8 weeks
Receives: Behavioral: Exergaming
ControlNo interventionAsked to continue with their normal daily routine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. VO2max (Maximal Aerobic Capacity)

    Measured: 8 weeks

Secondary outcomes (9)
  1. Daily average energy expenditure

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  2. Daily average number of steps

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  3. Daily time in sedentary activity (< 3.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  4. Daily time in moderate intensity activity (3.0-6.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  5. Daily time in vigorous intensity activity (6.0-9.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  6. Daily time in very vigorous intensity activity (>9.0 metabolic equivalents = METs)

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  7. Daily average total physical activity duration

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (8 weeks).

    Measured: 8 weeks

  8. Bioelectrical impedance

    Measured by activity monitors (SenseWear Armband) which participants will wear for one week at start of intervention period and after intervention period (weeks).

    Measured: 8 weeks

  9. Blood Pressure

    Measured: 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Oct 2019
  2. Study start14 Oct 2019
  3. Primary completion1 Mar 2020
  4. Study completion1 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
29 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04112329
Sponsor's protocol ID
2019/1083
Status last verified
May 2021
First submitted
30 Sep 2019
Last updated
13 May 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Berg J, Haugen G, Wang AI, Moholdt T. High-intensity exergaming for improved cardiorespiratory fitness: A randomised, controlled trial. Eur J Sport Sci. 2022 Jun;22(6):867-876. doi: 10.1080/17461391.2021.1921852. Epub 2021 May 16.

    PubMed 33944698

Questions about this trial

What is this clinical trial studying?

A study testing Exergaming in people with Sedentary Lifestyle, run by Norwegian University of Science and Technology at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

VO2max (Maximal Aerobic Capacity) (time frame: 8 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04112329, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 May 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in